← Research index  ·  Disorder page  ·  Source YAML

Cross-provider research synthesis

Acute Annular Outer Retinopathy

MONDO:0017299 Curated 2026-07-04T00:00:00Z 9 harmonized findings
falcon · 23 citations openscientist · 27 citations
Concordant asserts the finding Partial supports a weaker/qualified form Contradictory conflicts with it Silent does not address it

Harmonized findings

Acute annular outer retinopathy (AAOR) is a rare acute-onset disorder of the outer retina, characterized by an annular peri-/peripapillary gray-white ring with sudden scotoma, and is widely regarded as a variant within the acute zonal occult outer retinopathy (AZOOR) spectrum / white dot syndrome family.

UNANIMOUS INTEGRATED
pathophysiologyphenotype
ProviderStanceScoreEvidence
falcon CONCORDANT 95% Acute annular outer retinopathy (AAOR) is a rare acute-onset outer retinal disorder characterized clinically by an annular peri-/peripapillary gray-white ring or demarcation line and sudden onset of a scotoma, with evidence of outer retinal disruption on multimodal testing.
Falcon defines AAOR as a rare acute-onset outer retinal disorder with an annular gray-white ring and scotoma, and elsewhere frames it as an AZOOR-complex/variant entity.
openscientist CONCORDANT 95% Acute Annular Outer Retinopathy (AAOR) is a rare inflammatory disease of the outer retina, classified within the white dot syndrome (WDS) family and the AZOOR complex.
OpenScientist gives the same characterization, explicitly placing AAOR in the white dot syndrome family and AZOOR complex.
PMID:11078842, PMID:8340485

The etiology of AAOR is unknown, with the leading hypotheses being an immune-mediated (autoimmune) and/or post-viral/post-infectious process; it is an acquired condition, not a heritable monogenic disease.

UNANIMOUS INTEGRATED
pathophysiologygenetic_factor
ProviderStanceScoreEvidence
falcon CONCORDANT 90% The aetiology of AAOR remains unknown, although an autoimmune mechanism has been suggested.
Falcon states the etiology is unknown with an autoimmune mechanism suggested, and treats AAOR as an acquired outer retinopathy rather than a heritable disease.
openscientist CONCORDANT 90% The condition is considered to have a complex, non-genetic, likely autoimmune or post-infectious pathogenesis.
OpenScientist independently frames the pathogenesis as non-genetic and likely autoimmune or post-infectious.
PMID:30455116, PMID:38454854

Antiretinal antibodies have been detected in AAOR/AZOOR patients, supporting an autoimmune attack directed at photoreceptor/outer-retinal antigens.

UNANIMOUS INTEGRATED
pathophysiologydiagnosis
ProviderStanceScoreEvidence
falcon CONCORDANT 80% antiretinal antibodies; infectious workups often negative.
Falcon lists antiretinal antibodies among the reported associations and cites a 2008 case series reporting immunohistochemistry-based antiretinal reactivity.
DOI:10.1001/archophthalmol.2007.5
openscientist CONCORDANT 90% AZOOR could be an autoimmune disease. All AZOOR patients tested using molecular biological methods had antiretinal antigens
OpenScientist cites Tagami et al. reporting antiretinal antigens/antibodies targeting photoreceptors in all AZOOR patients tested.
PMID:25266678, PMID:18195232

The primary lesion in AAOR is at the photoreceptor outer segments, with the retinal pigment epithelium (and choriocapillaris) involved only secondarily.

MAJORITY INTEGRATED
pathophysiology
ProviderStanceScoreEvidence
openscientist CONCORDANT 95% the primary damage was identified at the level of the photoreceptor outer segments with an intact choriocapillaris and retinal pigment epithelium (RPE) layer, these structures being only secondarily involved
OpenScientist cites Herbort et al. establishing photoreceptor-outer-segment damage as primary with intact choriocapillaris/RPE that are only secondarily involved.
PMID:34209956
falcon PARTIAL 60% Loss of ellipsoid/photoreceptor layers within the ring; abrupt annulus-margin changes with nodular RPE hyperreflectivity/disruption and atrophy
Falcon documents photoreceptor/ellipsoid-zone loss with RPE atrophy as a downstream/evolving feature, but does not assert the explicit photoreceptor-primary / choriocapillaris-intact hierarchy that OpenScientist draws from Herbort.

AAOR follows a staged clinical course: an acute (progressive) phase with the expanding annular ring, followed by stabilization, then a chronic/atrophic phase with RPE and pigmentary changes.

MAJORITY LEAD
prognosisphenotype
ProviderStanceScoreEvidence
openscientist CONCORDANT 90% The clinical course was subdivided acutely progressive stage (APS), stationary stage (SS) and atrophic stage (AS) (1-3 weeks, 3 weeks to 3 months and >3 months, respectively)
OpenScientist reports the formal three-stage staging (APS/SS/AS) with explicit time bins from Chen et al. 2025.
PMID:40446848
falcon PARTIAL 50% A pragmatic staging consistent with case descriptions
Falcon proposes only an informal acute/subacute/chronic staging derived from case descriptions, without the formal APS/SS/AS labels or defined time windows OpenScientist reports.

Visual prognosis in AAOR is critically determined by macular/foveal involvement: eyes without macular involvement retain good acuity (~20/20), whereas foveal involvement can lead to severe vision loss.

UNANIMOUS INTEGRATED
prognosisphenotype
ProviderStanceScoreEvidence
openscientist CONCORDANT 95% Seven eyes of 5 patients showed no macular involvement with best corrected visual acuity (BCVA) of 20/20, while 5 eyes of 5 patients showed macular involvement with poorer BCVA of HM-20/400 at the last visit
OpenScientist quantifies the macular-involvement dichotomy (20/20 without vs HM-20/400 with) from Chen et al.
PMID:40446848
falcon CONCORDANT 75% Severe vision loss is possible when the lesion crosses the fovea
Falcon agrees that foveal involvement drives severe vision loss, though it does not tabulate the paired acuity figures OpenScientist provides.

There is no proven, evidence-based treatment for AAOR; corticosteroids, immunosuppressants, and antivirals have been tried anecdotally with inconsistent outcomes.

UNANIMOUS INTEGRATED
treatment
ProviderStanceScoreEvidence
openscientist CONCORDANT 95% Various treatments have been attempted in patients with AZOOR--including systemic corticosteroids, other systemic immunosuppressive agents, and different antimicrobials--but none have been proven effective
OpenScientist quotes Monson & Smith stating no attempted treatment has been proven effective.
PMID:21056448
falcon CONCORDANT 90% reported interventions are anecdotal and based on small numbers
Falcon states there is no established, evidence-based therapy and that reported interventions (steroids, antivirals) are anecdotal.
DOI:10.1016/S0002-9394(00)00560-2

Presenting features of AAOR are acute photopsia, scotoma / visual field loss (including enlarged blind spot), and variable blurred vision, with acuity depending on foveal involvement.

UNANIMOUS INTEGRATED
phenotype
ProviderStanceScoreEvidence
openscientist CONCORDANT 90% photopsia (87%), blurred vision (57%), and scotoma (57%)
OpenScientist gives quantified presenting-symptom frequencies from the Ramtohul et al. multicenter cohort.
PMID:40436146
falcon CONCORDANT 70% Sudden or subacute photopsias and visual-field loss/enlarged blind spot; may have decreased color vision, RAPD, floaters; visual acuity ranges from normal to severe loss depending on foveal involvement
Falcon lists the same core presenting symptoms qualitatively but without the quantified frequencies OpenScientist provides.

AAOR is ultra-rare (only a small number of reported cases); the broader AZOOR spectrum shows a female predominance (male:female ~1:3.2, mean age in the third-to-fourth decade), though AAOR case series themselves span both sexes and a wide age range.

MAJORITY LEAD
epidemiologyphenotype
ProviderStanceScoreEvidence
openscientist CONCORDANT 85% predominantly white individuals, average age at presentation was 36.7 years, and the male:female ratio was 1:3.2
OpenScientist reports the AZOOR/AAOR demographic profile (Caucasian, mean 36.7 years, female-predominant 1:3.2) from Monson & Smith.
PMID:21056448
falcon PARTIAL 50% Demographic patterns suggested by AZOOR-complex literature (young women) may apply broadly, but AAOR itself has been described in both sexes and across a wide age range in case series.
Falcon qualifies the female-predominance generalization, noting AAOR itself has been reported in both sexes and across a wide age range - a nuance, not a direct contradiction of the AZOOR-spectrum demographic signal.

Narrative

Overview

Both providers frame acute annular outer retinopathy (AAOR) as an ultra-rare acute outer retinal disorder within the AZOOR spectrum, defined by an annular peripapillary gray-white ring with acute scotoma and photopsia, primary photoreceptor/outer-retinal injury on multimodal imaging, an unknown but likely immune-mediated/post-viral etiology, and no proven treatment. Falcon used the pathophysiology-focused prompt and is mechanism-first and more concise; OpenScientist ran the broader disease-characteristics prompt and contributes more recent, quantitative clinical detail.

Agreement

The reports converge on the core picture: AAOR is a rare acquired (non-hereditary) outer retinopathy in the AZOOR/white-dot-syndrome family; etiology is unknown but autoimmune and/or post-infectious; antiretinal antibodies support immune targeting of photoreceptors; the defining lesion is at the photoreceptor/ellipsoid-zone level with RPE change as a downstream feature; presenting symptoms are acute photopsia, scotoma, and visual field loss; foveal/macular involvement governs visual prognosis; and no therapy (corticosteroids, immunosuppressants, antivirals) has proven effective.

Divergence

OpenScientist adds newer, quantitative literature (Chen 2025 formal three-stage APS/SS/AS course; Ramtohul 2025 symptom frequencies and the ASHH OCT sign; paired macular-involvement acuity figures; Herbort's explicit photoreceptor-primary-vs-choriocapillaritis distinction) and a firmer female-predominance demographic (1:3.2). Falcon, drawing on older case-report/DOI sources, offers only informal acute/subacute/chronic staging, qualitative symptom lists, and notably qualifies the female-predominance claim by stressing that AAOR itself spans both sexes and a wide age range. The two citation sets do not overlap, so they represent complementary review trails rather than conflicting claims; no direct contradictions were found.

Integration

Findings on disease definition/AZOOR-spectrum placement, unknown autoimmune/post-viral etiology, antiretinal antibodies, photoreceptor-primary injury with secondary RPE change, macular-involvement-dependent prognosis, the no-proven-treatment status, and the acute photopsia/scotoma symptom set align with and reinforce the existing kb/disorders/Acute_Annular_Outer_Retinopathy entry and are marked INTEGRATED.

Not integrated (leads)

The formal Chen 2025 three-stage staging and the detailed epidemiology/demographic profile are retained as research LEADs pending fetch-reference verification of the underlying PMIDs before promotion; they refine rather than change the curated mechanism.

Cross-provider synthesis comparing falcon (Edison Scientific Literature, pathophysiology-focused, DOI-based citations) and openscientist (openscientist-autonomous, comprehensive 15-domain, PMID-based citations). best_matching_text values are verbatim excerpts from the respective report files; consensus is derived, not authored. No direct contradictions were identified - divergence is coverage, recency, and quantification (OpenScientist adds Chen 2025 staging, Ramtohul 2025 cohort data, and Herbort's mechanistic distinction), plus Falcon's qualification of the female-predominance signal. citations mirror each provider's own reference identifiers and were not independently fetch-verified in this synthesis.